Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-11
1997-07-08
Dees, Jose G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514340, 514345, 514349, 514312, 514311, 514313, 514314, 514269, 514309, 514307, 514444, 514445, 514447, 514249, 514248, 514252, 514375, A61K 31505, A61K 3144, A61K 3147, A61K 3138
Patent
active
056461534
ABSTRACT:
This invention relates to bis mono- and/or bicyclic aryl and/or heteroaryl compounds exhibiting protein tyrosine kinase inhibition activity. More specifically, it relates to the method of inhibiting abnormal cell proliferation in a patient suffering from a disorder characterized by such proliferation comprising the administration thereto of an EGF and/or PDGF receptor inhibiting effective amount of said bis mono- and/or bicyclic aryl and/or heteroaryl compound and to the preparation of said compounds and their use in pharmaceutical compositions used in this method.
REFERENCES:
patent: 3715358 (1973-02-01), Witzel et al.
patent: 3718743 (1973-02-01), Shen et al.
patent: 3985749 (1976-10-01), Foster
patent: 4322420 (1982-03-01), Kobayashi et al.
patent: 4464375 (1984-08-01), Kobayashi et al.
patent: 4465686 (1984-08-01), Lesher et al.
patent: 4599423 (1986-07-01), Lesher et al.
patent: 4661499 (1987-04-01), Young et al.
patent: 5134148 (1992-07-01), Crawley et al.
Tetrahedron, vol. 38, No. 22, pp. 3347-3354 (1982) Tamao et al. Nickel-Phosphine Complex-Catalyzed Grignard Coupling--II Grignard Coupling of Heterocyclic Compounds.
Synthesis, pp. 564-565 (Jul. 1986) Yamamoto et al. General Method for Synthesis of Bipyridines: Palladium Catalyzed Cross-Coupling Reaction of Trimethylstannylpyridin.
Chem. Pharm. Bull., vol. 30, No. 6, pp. 2003-2010 (1982) Yamamoto et al. Studies on Organometallic Compounds. III. Reaction of Trimethylstannylazines with Acyl Chlorides. A.
Heterocycles, vol. 23, No. 9, pp. 2375-2386 (1985) Ishikura et al. A Simple and Regioselective Preparation of 2-or 3-Substituted Quinoline Derivatives Via Dialkylquinolylboranes.
J. Am. Chem. Soc., vol. 111, No. 3, pp. 877-891 (1989) Stern et al. Potential-Dependent Surface Chemistry of 3-Pyridinecarboxylic Acid (Niacin) and Related Compounds at Pt(111) Electrodes.
Chemical Abstract, vol. 84:164632t, p. 453 (1976) Yoshina Quinoline Derivatives.
Chemical Abstract, vol. 103:123292z, p. 709 (1985) Barker et al. Dehalogenation of 1-Halothienyldi-and -Tetrahydroisoquinoline s by Sodium Methoxide in Dimethyl Sulfoxide.
Chemical Abstract, vol. 108:55860j, p. 704 (1988) Epling et al. Sulfur-Containing 2-Arylquinolinemethano Is as Potential Antimalarials.
Beilstein-Band EIII/IV 21, p. 2436 (1978) 3-Phenyl-chinolin-7,8-diol.
J.Heterocyclic Chem., vol. 20, pp. 1739-1740 (1983) Saeed et al. Preparation of Phenylquinoxaline from alpha,alpha-Diaminoketones and Dimethyl-o-phenylenediamine.
Maguire Martin P.
Myers Michael R.
Persons Paul E.
Spada Alfred P.
Cebulak Mary C.
Dees Jos,e G.
Nicholson James A.
Parker III Raymond S.
Rhone-Poulenc Rorer Pharmaceuticals Inc.
LandOfFree
Bis mono- and bicyclic aryl and heteroaryl compounds which inhib does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bis mono- and bicyclic aryl and heteroaryl compounds which inhib, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bis mono- and bicyclic aryl and heteroaryl compounds which inhib will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2409024